<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>蛋白质模拟 on AI内参</title>
    <link>http://192.168.50.247:1313/tags/%E8%9B%8B%E7%99%BD%E8%B4%A8%E6%A8%A1%E6%8B%9F/</link>
    <description>Recent content in 蛋白质模拟 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Fri, 11 Jul 2025 05:40:07 +0800</lastBuildDate>
    <atom:link href="http://192.168.50.247:1313/tags/%E8%9B%8B%E7%99%BD%E8%B4%A8%E6%A8%A1%E6%8B%9F/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>微软AI又“整活儿”：蛋白质“灵魂舞者”终于被驯服，新药研发要起飞？</title>
      <link>http://192.168.50.247:1313/insights/article-20250711054007254-0/</link>
      <pubDate>Fri, 11 Jul 2025 05:40:07 +0800</pubDate>
      <guid>http://192.168.50.247:1313/insights/article-20250711054007254-0/</guid>
      <description>微软新推出的BioEmu AI系统，能以惊人的速度模拟蛋白质的复杂动态，将传统需要几年完成的模拟任务缩短至几小时，极大地加速了药物研发进程。结合其另一款“神兵利器”AI²BMD的量子级精度，微软正用AI重新定义生命科学的研究范式，让新药研发从“龟速”变“光速”。</description>
    </item>
  </channel>
</rss>
